OMNI BIO PHARMACEUTICAL, INC.
CIK 0001389870
Revenue (TTM)
$0
Q3 Feb 2015
Net Income (TTM)
−$3.98M
+66.2% YoY
Q3 Feb 2015
EPS Diluted (TTM)
—
Q3 Feb 2015
Gross Margin
—
Q3 Feb 2015
Operating Margin
—
Q3 Feb 2015
Net Margin
—
Q3 Feb 2015
Free Cash Flow (TTM)
−$1.78M
Q3 Feb 2015
Cash
$852.37K
Q3 Feb 2015
Total Debt
—
Q3 Feb 2015
Shares Outstanding
40.46M sh
Q3 Feb 2015
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.